Proteomic mass spectrometry analysis of proteins within the tumor microenvironment revealed that treatments with a fascin inhibitor and an anti-PD-1 antibody, compared with anti-PD-1 treatment alone, increased the levels of proteins involved in vesicle-mediated transport and clathrin-mediated endocytosis [37]. This evidence concerns the gene FSCN1 and neoplasm.